Recent Quotes
View Full List
My Watchlist
Ameramex Intl Inc
BioNexus Gene Lab Corp - Common stock
Blackrock Silver Corp
Borealis Foods Inc. - Class A Common Shares
Collective Audience, Inc. - Common Stock
Direxion Daily Semiconductor Bear 3X ETF
Dorchester Minerals, L.P. - Common Units Representing Limited
First Trust SSI Strategic Convertible Securities ETF
Global X AI Semiconductor & Quantum ETF
Hamilton Enhanced Canadian Bank ETF
Imperalis Holding Corp
Invesco S&P 500 Equal Weight Consumer Staples ETF
Kasikornbank Pcl ADR
Mitsui O.S.K. Lines ADR
Origin Agritech Limited - Ordinary Shares
PLUS THERAPEUTICS, Inc. - Common Stock
Pine Tree Acquisition Corp. - Units
Proof Acquisition Corp I Cl A
Retractable Technologies, Inc. Common Stock
Salem Media Group, Inc. - Class A Common Stock
Sientra, Inc. - Common Stock
Silgan Holdings Inc. - Common Stock
Teads Holding Co. - Common Stock
Thyssenkrupp Ag ADR
VSE Corporation - Tangible Equity Units
Wealthfront Corporation - Common Stock
Wipro Limited Common Stock
enGene Therapeutics Inc. - Common Stock
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Propanc Biopharma, Inc. - Common Stock
(NQ:
PPCB
)
0.3420
+0.0005 (+0.15%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Propanc Biopharma, Inc. - Common Stock
< Previous
1
2
3
Next >
Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital
October 15, 2025
Initial Conversion Price of $5.00 Per Share Representing a 280% Premium Over the Company’s Recent Closing Price of $1.78
From
Propanc Biopharma, Inc.
Via
GlobeNewswire
Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy
October 07, 2025
From
Propanc Biopharma, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.